Literature DB >> 20712566

Targeting protein-protein interactions: a promising avenue of anti-HIV drug discovery.

P Zhan1, W Li, H Chen, X Liu.   

Abstract

In recent years, the number of useful chemical biology information of protein-protein interactions in the HIV life cycle and related inhibitors, is growing rapidly, which makes protein-protein interactions a new investigative area for antiviral drug intervention. This review will summarize recent work in this field, mainly focusing on the utilization of small molecules targeted against a variety of protein-protein interactions that have great therapeutic feasibility for HIV infection, and lastly outline some other important protein-protein interactions with a potential to advance into novel anti-HIV drug targets in future.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20712566     DOI: 10.2174/092986710793176357

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  5 in total

1.  Crystal Structure of the Dimerized N Terminus of Porcine Circovirus Type 2 Replicase Protein Reveals a Novel Antiviral Interface.

Authors:  Gao Luo; Xiongfei Zhu; Yang Lv; Bomin Lv; Jin'e Fang; Shengbo Cao; Huanchun Chen; Guiqing Peng; Yunfeng Song
Journal:  J Virol       Date:  2018-08-29       Impact factor: 5.103

2.  Structure-based design, synthesis, and characterization of dual hotspot small-molecule HIV-1 entry inhibitors.

Authors:  Judith M LaLonde; Young Do Kwon; David M Jones; Alexander W Sun; Joel R Courter; Takahiro Soeta; Toyoharu Kobayashi; Amy M Princiotto; Xueling Wu; Arne Schön; Ernesto Freire; Peter D Kwong; John R Mascola; Joseph Sodroski; Navid Madani; Amos B Smith
Journal:  J Med Chem       Date:  2012-04-23       Impact factor: 7.446

Review 3.  A New Class of Antiretroviral Enabling Innate Immunity by Protecting APOBEC3 from HIV Vif-Dependent Degradation.

Authors:  Ryan P Bennett; Jason D Salter; Harold C Smith
Journal:  Trends Mol Med       Date:  2018-03-30       Impact factor: 11.951

4.  A comparative study of short linear motif compositions of the influenza A virus ribonucleoproteins.

Authors:  Chu-Wen Yang
Journal:  PLoS One       Date:  2012-06-08       Impact factor: 3.240

Review 5.  Targeting protein-protein interaction interfaces in COVID-19 drug discovery.

Authors:  Chung-Ke Chang; Shan-Meng Lin; Roshan Satange; Shih-Chao Lin; Sin-Cih Sun; Hung-Yi Wu; Kylene Kehn-Hall; Ming-Hon Hou
Journal:  Comput Struct Biotechnol J       Date:  2021-04-15       Impact factor: 7.271

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.